Literature DB >> 15021916

SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.

Masaki Kamio1, Takafumi Yoshida, Hisanobu Ogata, Tsutomu Douchi, Yukihiro Nagata, Makoto Inoue, Mamoru Hasegawa, Yoshikazu Yonemitsu, Akihiko Yoshimura.   

Abstract

Human papilloma viruses (HPVs) are small double-stranded DNA viruses that infect mucosal and cutaneous epithelium and induce cervical cancer. It has been shown that interferon (IFN)gamma suppresses proliferation of HPV-infected cells by suppressing expression of HPV E7. Here, we found that IFNgamma induces not only suppression of E7 transcription but also proteasome-dependent degradation. Suppressor of cytokine signaling-1 (SOCS1)/JAB, a suppressor of cytokine signaling, is known to be induced by IFNgamma, and functions as an antioncogene against various hematopoietic oncogenic proteins. SOCS1 contains the SOCS-box, which is shown to recruit ubiquitin transferase to the molecules that interact with SOCS1. We found that SOCS1 interacted with HPV E7 protein and induced ubiquitination and degradation of E7 in a SOCS-box-dependent manner. SOCS1 overexpression also increased Rb protein levels and suppressed proliferation of cervical cancer cell lines infected with HPV. Moreover, E7 protein levels were higher and Rb protein levels were lower in SOCS1-deficient fibroblasts infected with retrovirus vector carrying E7 gene than in wild-type fibroblasts. E7 induced anchorage-independent growth in SOCS1-deficient fibroblasts, but not in wild-type cells. These data suggested that SOCS1 plays an important role in regulating the levels of E7 protein and their transforming potential, and could be a new therapeutic tool for HPV-mediated tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021916     DOI: 10.1038/sj.onc.1207453

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.

Authors:  R C Sobti; Neha Singh; Showket Hussain; Vanita Suri; Raje Nijhawan; A C Bharti; Mausumi Bharadwaj; B C Das
Journal:  Cell Oncol (Dordr)       Date:  2011-09-21       Impact factor: 6.730

2.  USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity.

Authors:  Ching-Hui Lin; Hung-Shu Chang; Winston C Y Yu
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

Review 3.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

4.  Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.

Authors:  Asma Beldi-Ferchiou; Nour Skouri; Cyrine Ben Ali; Ines Safra; Abderrahman Abdelkefi; Saloua Ladeb; Karima Mrad; Tarek Ben Othman; Mélika Ben Ahmed
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

5.  HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.

Authors:  Rossella Marullo; Erica Werner; Hongzheng Zhang; Georgia Z Chen; Dong M Shin; Paul W Doetsch
Journal:  Carcinogenesis       Date:  2015-09-08       Impact factor: 4.944

6.  Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.

Authors:  Masahiro Maruoka; Shin Kedashiro; Yuki Ueda; Kiyohito Mizutani; Yoshimi Takai
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

7.  SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag.

Authors:  Akihide Ryo; Naomi Tsurutani; Kenji Ohba; Ryuichiro Kimura; Jun Komano; Mayuko Nishi; Hiromi Soeda; Shinichiro Hattori; Kilian Perrem; Mikio Yamamoto; Joe Chiba; Jun-Ichi Mimaya; Kazuhisa Yoshimura; Shuzo Matsushita; Mitsuo Honda; Akihiko Yoshimura; Tatsuya Sawasaki; Ichiro Aoki; Yuko Morikawa; Naoki Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

8.  Model-based analysis of interferon-beta induced signaling pathway.

Authors:  Jaroslaw Smieja; Mohammad Jamaluddin; Allan R Brasier; Marek Kimmel
Journal:  Bioinformatics       Date:  2008-08-19       Impact factor: 6.937

Review 9.  The human papillomavirus E7 oncoprotein.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virology       Date:  2008-11-12       Impact factor: 3.616

10.  HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).

Authors:  Stéphanie Olière; Eduardo Hernandez; Agnès Lézin; Meztli Arguello; Renée Douville; Thi Lien-Anh Nguyen; Stéphane Olindo; Gérard Panelatti; Mirdad Kazanji; Peter Wilkinson; Rafick-Pierre Sékaly; Raymond Césaire; John Hiscott
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.